Eli Lilly and Company (NYSE:LLY): Current price $30.70
Lilly and Kowa Pharmaceuticals America have announced the results of a study evaluating the efficacy of Livalo (pitavastatin) 4 mg compared with pravastatin 40 mg in lowering low-density lipoprotein cholesterol in HIV-infected adults with high cholesterol, or dyslipidemia. The evaluation was created as a superiority trial for the primary endpoint, percent reduction in LDL-C, and evaluated HIV-infected adults with dyslipidemia,with and without viral Hepatitis B or C. The study achieved its primary endpoint.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.